BioVie Inc. Other Selling, General and Administrative Expense
BioVie Inc. (BIVI) reported Other Selling, General and Administrative Expense of $5.21 thousand for the 12-month period ending 2024-06-30, per its 10-K filed 2024-09-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherSellingGeneralAndAdministrativeExpense · last filed 2026-08-06
- BioVie Inc. other selling, general and administrative expense for the quarter ending 2024-03-31 was $5.21K.
- BioVie Inc. other selling, general and administrative expense for fiscal 2024 was $5.21K.
| Period end | Other Selling, General and Administrative Expense 0 month | Other Selling, General and Administrative Expense 3 month | Other Selling, General and Administrative Expense 12 month |
|---|---|---|---|
| 2024-06-30 | $5.21K 10-K · filed 2024-09-30 | ||
| 2024-03-31 | $5.21K 10-Q · filed 2024-05-14 | ||
| 2024-02-12 | $5.21K S-1/A · filed 2026-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |